Taiwan · Delayed Price · Currency is TWD Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 7.90 billion. The enterprise value is 6.53 billion.
| Market Cap | 7.90B |
| Enterprise Value | 6.53B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Jul 28, 2026 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 69.30M |
| Shares Outstanding | 69.30M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 4.26% |
| Owned by Institutions (%) | 6.34% |
| Float | 47.56M |
Valuation Ratios
The trailing PE ratio is 13.48.
| PE Ratio | 13.48 |
| Forward PE | n/a |
| PS Ratio | 3.56 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.24 |
| P/FCF Ratio | 13.29 |
| P/OCF Ratio | 11.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.30, with an EV/FCF ratio of 10.98.
| EV / Earnings | 11.07 |
| EV / Sales | 2.94 |
| EV / EBITDA | 7.30 |
| EV / EBIT | 9.06 |
| EV / FCF | 10.98 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.75 |
| Quick Ratio | 2.35 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.56 |
| Debt / FCF | 0.84 |
| Interest Coverage | 105.74 |
Financial Efficiency
Return on equity (ROE) is 17.29% and return on invested capital (ROIC) is 26.46%.
| Return on Equity (ROE) | 17.29% |
| Return on Assets (ROA) | 9.36% |
| Return on Invested Capital (ROIC) | 26.46% |
| Return on Capital Employed (ROCE) | 18.25% |
| Weighted Average Cost of Capital (WACC) | 4.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 4.11 |
Taxes
In the past 12 months, Bioteque has paid 162.68 million in taxes.
| Income Tax | 162.68M |
| Effective Tax Rate | 21.63% |
Stock Price Statistics
The stock price has increased by +0.44% in the last 52 weeks. The beta is 0.12, so Bioteque's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +0.44% |
| 50-Day Moving Average | 115.95 |
| 200-Day Moving Average | 119.34 |
| Relative Strength Index (RSI) | 45.56 |
| Average Volume (20 Days) | 58,428 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.22 billion and earned 589.44 million in profits. Earnings per share was 8.46.
| Revenue | 2.22B |
| Gross Profit | 1.00B |
| Operating Income | 720.90M |
| Pretax Income | 752.12M |
| Net Income | 589.44M |
| EBITDA | 877.04M |
| EBIT | 720.90M |
| Earnings Per Share (EPS) | 8.46 |
Balance Sheet
The company has 1.87 billion in cash and 498.18 million in debt, with a net cash position of 1.37 billion or 19.80 per share.
| Cash & Cash Equivalents | 1.87B |
| Total Debt | 498.18M |
| Net Cash | 1.37B |
| Net Cash Per Share | 19.80 |
| Equity (Book Value) | 3.53B |
| Book Value Per Share | 50.91 |
| Working Capital | 1.63B |
Cash Flow
In the last 12 months, operating cash flow was 703.17 million and capital expenditures -108.55 million, giving a free cash flow of 594.62 million.
| Operating Cash Flow | 703.17M |
| Capital Expenditures | -108.55M |
| Depreciation & Amortization | 156.60M |
| Net Borrowing | -180.25M |
| Free Cash Flow | 594.62M |
| FCF Per Share | 8.58 |
Margins
Gross margin is 45.15%, with operating and profit margins of 32.46% and 26.54%.
| Gross Margin | 45.15% |
| Operating Margin | 32.46% |
| Pretax Margin | 33.86% |
| Profit Margin | 26.54% |
| EBITDA Margin | 39.49% |
| EBIT Margin | 32.46% |
| FCF Margin | 26.77% |
Dividends & Yields
This stock pays an annual dividend of 5.50, which amounts to a dividend yield of 4.80%.
| Dividend Per Share | 5.50 |
| Dividend Yield | 4.80% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 58.78% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 4.73% |
| Earnings Yield | 7.46% |
| FCF Yield | 7.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
| Last Split Date | Aug 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.8006917977 |
Scores
Bioteque has an Altman Z-Score of 5.71 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.71 |
| Piotroski F-Score | 8 |